Universitaetsklinikum Krems — Clinical Trial Site

36 Registered trials

17 Currently recruiting

Organisation

Universitaetsklinikum Krems

Location

Krems An Der Donau, Austria

Identifier

ORG-100046221

Address

Mitterweg 10, 3500, Austria

Departments

Abteilung für Pneumologie
Clinical Department for Internal Medicine 2
Clinical Department for Internal Medicine II
Clinical Department for Pneumology
Clinical Department of Internal Medicine 2
Department for Internal Medicine II
Department for Pneumology
Department of Internal Medicine II
Department of Internal Medicine II, Clinical Department of Oncology and Hematology
Department of Pneumology
Department Pneumology
Division of Internal Medicine 2
Division of Pneumology
Innere Medizin II Hämato-Onkologie
Internal Medicine 2
Klinische Abteilung fue Innere Medizin 2
Klinische Abteilung fuer Pneumologie
Klinische Abteilung für Pneumologie
Molekulare Onkologie/Hämatologie
Oncology and hematology
Oncology/Hematology
Pneumologie
Privatuniversität für Gesundheitswissenschaften Abteilung für Innere Medizin II
Universitätsklinikum Krems, Innere Medizin II Hämato-Onkologie

Clinical trials at this site (36)

Search interface

A trial to determine the safety and effectiveness of CC-92480 in combination with bortezomib and dexamethasone as compared to pomalidomide i… Ended

2023-509859-13-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-11-09
A Phase 2 Study of Tarlatamab in Patients with Small Cell Lung Cancer (SCLC). Ended

2024-511837-37-00 Relapsed/Refractory Small Cell Lung Cancer 4 2021-12-21
Treatment combination of Durvalumab, Tremelimumab, Enfortumab Vedotin in patients with muscle invasive bladder cancer ineligible to cisplati… Ended

2023-507342-84-00 Bladder Cancer 5 2021-10-26
Isatuximab in combination with Lenalidomide-Dexamethasone compared to Lenalidomide-Dexamethasone in elderly patients (aged ≥70 years) with n… Ended

2024-515581-13-00 Isatuximab in combination with Lenalidomide-Dexamethaso 4 2021-10-20
MagnetisMM-5: A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dex… Ended

2023-509208-14-00 MULTIPLE MYELOMA 5 2021-09-28
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specifi… Ended

2024-511798-31-00 KRAS p.G12C Mutant Advanced Solid Tumors 7 2019-05-31
Elotuzumab (E) in Combination with Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) versus KRd prior to and following Autologous Stem Cel… Ended

2024-515783-31-00 Newly Diagnosed Multiple Myeloma 5 2018-08-24
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
A randomized phase III non-inferiority trial assessing lenalidomide, bortezomib and dexame-thasone induction therapy with either intravenous… Ended

2024-516300-41-00 Multiple Myeloma 5 2023-03-07
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05
A study of Chemo only versus Chemo plus Nivo with or without BMS986205, Followed by Post- Surgery Therapy with Nivo or Nivo and BMS986205 in… Ended

2024-512158-12-00 Bladder Cancer Muscle-Invasive Bladder Cancer 5 2018-12-14